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Elevated lipid oxidation is associated with
exceeding gestational weight gain
recommendations and increased neonatal
anthropometrics: a cross-sectional analysis
Jill M. Maples1* , Samantha F. Ehrlich2, Nikki B. Zite1, Kevin J. Pearson3, W. Todd Cade4, Courtney J. Riedinger1,
Maire M. Blankenship5 and Rachel A. Tinius6
Abstract
Background: Deviations from gestational weight gain (GWG) recommendations are associated with unfavorable
maternal and neonatal outcomes. There is a need to understand how maternal substrate metabolism, independent
of weight status, may contribute to GWG and neonatal outcomes. The purpose of this study was to explore the
potential link between maternal lipid oxidation rate, GWG, and neonatal anthropometric outcomes.
Methods: Women (N = 32) with a lean pre-pregnancy BMI were recruited during late pregnancy and substrate
metabolism was assessed using indirect calorimetry, before and after consumption of a high-fat meal. GWG was
categorized as follows: inadequate, adequate, or excess. Shortly after delivery (within 48 h), neonatal
anthropometrics were obtained.
Results: Using ANOVA, we found that fasting maternal lipid oxidation rate (grams/minute) was higher (p = 0.003)
among women with excess GWG (0.1019 ± 0.0416) compared to women without excess GWG (inadequate =
0.0586 ± 0.0273, adequate = 0.0569 ± 0.0238). Findings were similar when lipid oxidation was assessed post-meal
and also when expressed relative to kilograms of fat free mass. Absolute GWG was positively correlated to absolute
lipid oxidation expressed in grams/minute at baseline (r = 0.507, p = 0.003), 2 h post-meal (r = 0.531, p = 0.002), and
4 h post-meal (r = 0.546, p = 0.001). Fasting and post-meal lipid oxidation (grams/minute) were positively correlated
to neonatal birthweight (fasting r = 0.426, p = 0.015; 2-hour r = 0.393, p = 0.026; 4-hour r = 0.540, p = 0.001) and also
to neonatal absolute fat mass (fasting r = 0.493, p = 0.004; 2-hour r = 0.450, p = 0.010; 4-hour r = 0.552, p = 0.001).
Conclusions: A better understanding of the metabolic profile of women during pregnancy may be critical in truly
understanding a woman’s risk of GWG outside the recommendations. GWG counseling during prenatal care may
need to be tailored to women based not just on their weight status, but other metabolic characteristics.
Keywords: Birthweight, Gestational weight gain, Lipid metabolism, Lipid oxidation, Neonatal anthropometrics,
Neonatal fat mass, Pregnancy
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Background
Deviations from the guidelines for gestational weight
gain (GWG) from the US National Academy of
Medicine (NAM; previously known as the Institute of
Medicine) have been associated with unfavorable mater-
nal and infant outcomes [1]. For example, exceeding the
GWG recommendations during pregnancy increases the
risk of many adverse maternal outcomes [2–4] including
hypertensive disorders during pregnancy [5, 6], non-
elective surgical deliveries [7, 8], and postpartum weight
retention [3]. Adverse neonatal outcomes associated
with excessive GWG are linked with excessive fetal
growth and adiposity, which beyond the immediate risk
of birth trauma, have implications for future risk of
obesity and metabolic disease [9].
Because 70 % of women do not achieve GWG within
recommended ranges set forth by NAM [10], a greater
understanding of maternal metabolic factors that may
influence excess GWG is warranted. Prior work has fo-
cused on the impact that pre-pregnancy weight status
has on the risk of exceeding GWG recommendations
and there is a general consensus that women with
overweight/obesity are at greater risk of excessive GWG.
Work by Bugatto et al. suggests women with excess adi-
posity during pregnancy oxidize substrates (i.e. lipids
and carbohydrates) differently than lean women who are
pregnant [11]. Specifically, lipid oxidation during late
pregnancy is significantly higher among women that
were overweight, compared to lean pregnant women.
This is consistent with other reports that pregnant
women with overweight/obesity are resistant to insulin-
mediated suppression of lipid oxidation and lipolysis
[12, 13]. In this scenario, the lack of insulin-mediated
suppression of lipid metabolic processes could pro-
duce excess free fatty acids that could eventually be
stored and contribute to excessive GWG. However,
little is known about the potential impact that mater-
nal lipid oxidation during pregnancy may have on
exceeding GWG recommendations.
In addition, maternal substrate metabolism may con-
tribute to infant health outcomes. Indicators of maternal
lipid metabolism, such as maternal blood lipid profiles,
have been consistently associated with neonatal birth-
weight and adiposity [14]. Diderholm et al. evaluated the
impact that maternal lipolysis during late pregnancy had
on fetal growth outcomes and found that lipolysis during
late pregnancy was independently associated with fetal
size [15]. The authors suggest that elevated lipolysis
during late pregnancy could expose the fetus to excess
substrates, other than glucose, which has historically
been considered one of the most significant drivers of
fetal growth [15]. These relationships provide some
insight into maternal metabolism’s impact on neonatal
outcomes; however, limited research has evaluated the
impact of maternal lipid oxidation during late pregnancy
on fetal growth and adiposity. Understanding factors
that contribute to fetal overgrowth are important as
macrosomia can have direct negative impacts on obstet-
ric outcomes. For example, the risks of postpartum
hemorrhage, chorioamnionitis, and more severe vaginal
lacerations are elevated with macrosomia [16].
The purpose of this study was to explore the potential
link between maternal lipid oxidation, GWG, and neo-
natal anthropometric outcomes. Specifically, maternal
lipid oxidation rates during late pregnancy across
women with a lean pre-pregnancy BMI were stratified
by the NAM GWG recommendations (i.e. inadequate,
adequate, excess) and compared. Potential relationships
between maternal lipid oxidation, absolute GWG, and
neonatal anthropometric outcomes were also explored.
Because maternal weight status is an important factor
determining fetal growth and adiposity, we sought to ex-
plore the potential impact of maternal lipid oxidation on
neonatal anthropometric outcomes among exclusively
lean women. Studying only normoglycemic, lean preg-
nant women adds to the novelty of the project as mater-
nal weight status prior to pregnancy and clinically
diagnosed insulin resistance during pregnancy will not
confound relationships between GWG and outcomes.
Methods
This is a cross-sectional study design that took place at a
single academic institution. All study procedures were
approved by the Western Kentucky University’s Institu-
tional Review Board (IRB: 16–229, NCT: NCT03504319).
All methods were performed in accordance with the Code
of Federal Regulations on the Protection of Human Sub-
ject (45 CFR Part 46) and institutional research policies
and procedures. All participants were informed of the
benefits and risks of study participation prior to providing
written informed consent.
Participants
Participants were a subset from a larger previously pub-
lished cohort [17]. In the parent study, participants were
enrolled to determine the impact that overweight/obesity
has on substrate metabolism in response to a high-fat
meal challenge in late pregnancy. Participants were in-
cluded if they were 18–44 years old, had a confirmed
singleton viable pregnancy with no fetal abnormalities,
and had obstetric provider release to participate in the
study. Participants were excluded if they had multiple
gestation pregnancy, currently smoked or used illicit
drugs, or had a history of or current gestational diabetes,
pre-pregnancy diabetes or prior macrosomic infant. In
the parent study women with a self-reported BMI
between 18.5 and 45 kg/m2 were included. We found
that pregnant women with overweight/obesity were less
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metabolically flexible (i.e. had a dampened ability to in-
crease lipid oxidation in response to the high-fat meal)
compared to women that entered pregnancy with a lean
weight status. These findings suggest that women with a
lean pre-pregnancy weight status had a more favorable
metabolic profile. Because of this, and in an effort to
avoid the potential impact that excess pre-gravid adipos-
ity may have on lipid oxidation and GWG, only the lean
cohort from the parent study was chosen for the current
study. The subset consisted of lean pregnant women,
with a pre-pregnancy BMI between 18.5 and 25 kg/m2.
Including only women with a lean pre-pregnancy weight
status allowed us to more clearly investigate the role of
GWG on metabolic health during pregnancy, without
the potential confounding factor of excess adiposity.
Inclusion criteria included: Age 18–44, confirmed single-
ton viable pregnancy with no fetal abnormalities at
routine 18–22 ultrasonography, plan to deliver at The
Medical Center, completion of a standard of care gesta-
tional diabetes screen, and obstetric provider release to
participate in the study procedures. Exclusion criteria in-
cluded: multiple gestation pregnancy, inability to provide
voluntary informed consent, current use of illegal drugs
(cocaine, methamphetamine, opiates, etc.), current
smoker who does not consent to cessation, current
usage of daily medications by class: corticosteroids,
anti-psychotics (known to alter insulin resistance and
metabolic profiles), history of gestational diabetes,
pre-pregnancy diabetes or prior macrosomic (> 4500 g)
infant (each elevate the risk for gestational diabetes in the
current pregnancy, or undiagnosed gestational diabetes),
and dietary restrictions prohibiting them from consuming
the standardized meal/high-fat load.
Maternal metabolic study visit
The maternal metabolic study visit has been described
previously [17]. Briefly, participants reported to the lab
for the metabolic study visit in the morning after an
overnight fast. The night before the study visit, they
were provided with written instructions for preparing
and consuming a standardized diet. The instructions
were to consume a standardized 800 kilocalorie meal,
consisting of approximately 50 % carbohydrate, 30 % fat,
and 20 % protein, at 6pm the evening before the study
visit. Upon arrival to the lab for the study visit, the par-
ticipant’s weight, height, and vitals were taken. Body
composition was measured using skinfold anthropom-
etry at seven sites in triplicate using calipers (Harpenden
Skinfolds Caliper, Baty International, United Kingdom)
in order to determine maternal percent body fat. For
each participant, average skin fold thickness measures
were entered into a standardized equation that accounts
for age as previously described [18], a technique that has
been used during pregnancy in prior studies [19, 20].
Using the TrueOne Canopy Option and TrueOne
Metabolic Cart (TrueOne 2400, Parvomedics, Sandy,
UT), fasting metabolic measurements were assessed via
indirect calorimetry for approximately 15 min. Resting
metabolic rate, carbon dioxide production, and oxygen
consumption were measured. Using carbon dioxide
production and oxygen consumption rates, lipid and
carbohydrate oxidation rates were calculated as previ-
ously described [21]. A baseline, fasting blood draw was
obtained after the baseline resting metabolism measure-
ment was made. Participants then consumed a standard-
ized 1000-kcal meal within 20 min that was high in fat
and similar in composition to previous studies [22, 23].
The high-fat meal consisted of approximately 55 % fat,
30 % carbohydrate, and 15 % protein. Additional post-
prandial metabolic measurements (indirect calorimetry)
were taken 2 and 4 h after the high-fat meal was
consumed.
Neonatal study visit
Within 48 h of delivery, trained study team members
met with participants in the hospital postpartum unit.
Neonatal body composition (fat and lean mass) was
measured by skin fold thickness using calipers at the pa-
tients’ bedside. Skin fold measures at four sites (triceps,
subscapular, ilium, and thigh) were assessed in duplicate
in accordance with previously described protocols [24].
If duplicate readings were not within 0.5 mm of each
other, a third measure was taken, as is customary with
neonatal skinfold assessments [24]. Birthweight, length,
head circumference, and abdominal circumference was
assessed by nursing staff immediately after delivery and
recorded by the study team during the neonatal study
visit. Absolute fat mass was determined from the equa-
tion derived by Aris et al. [25].
Gestational weight gain outcome
Pre-pregnancy weight was self-reported and documented
during the metabolic study visit. Final delivery weight
was self-reported and documented during the neonatal
study visit. Total gestational weight gain was calculated
and categorized as follows: inadequate (below the NAM
guidelines), adequate (adhered to the NAM guidelines),
or excess (exceeded the NAM guidelines) based on the
calculated maternal pre-pregnancy BMI.
Statistical analyses
Normality of the distribution for each variable was tested
using Kolmogorov-Smirnov tests. For categorical data,
chi-square tests were used to assess differences between
groups. For continuous data, ANOVA with post-hoc
analyses or Kruskal-Wallis tests were used to assess
differences between groups. Pearson product-moment
correlation coefficients for normally distributed variables
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or Spearman’s rank-order correlation coefficient for
non-normally distributed variables were used to assess
the degree of the relationship between variables. Partial
correlations were used to adjust for potential con-
founders (e.g. baby’s sex, maternal pre-pregnancy BMI,
GWG). All data analyses were conducted using IBM
SPSS Statistics Version 26 (Armonk, New York).
Results
Thirty-two women met inclusion criteria. Participant
characteristics are shown in Table 1.
The mean age was 29.9 ± 4.7 years, 56 % were
primiparous, 97.0 % were non-Hispanic white, and 90 %
had completed a college education. There were no
differences in race, parity, or education across GWG
categories.
Lipid oxidation was higher among women that
exceeded the GWG recommendation at baseline and in
the postprandial states compared to women with
adequate GWG (Table 2; Fig. 1). Consistent with this,
respiratory quotient was lower among women with ex-
cessive GWG at all timepoints. Non-parametric methods
of comparison revealed the same results.
Absolute GWG was positively correlated to absolute
lipid oxidation expressed in grams/min at baseline (R=
0.507, P= 0.003), 2 hours post-meal (R= 0.531, P=0.002),
and 4 hours post-meal (R= 0.546, P= 0.001). Absolute
GWG was also positively correlated to lipid oxidation
Table 1 Characteristics of women stratified by gestational weight gain categorya







Gestational Weight Gain (kilograms)* 8.5±2.01 13.3±1.3 18.8±2.3†‡ <0.001*
Pre-pregnancy BMI* 21.2±1.5 22.0±1.7 23.0±1.5‡ 0.035*
Age (years) 26.7±6.6 31.6±3.8 29.8±3.7 0.082
Gestation Age at Study Visit (weeks) 34.5±2.7 34.5±1.7 34.3±1.6 0.977
Gestation Age at Delivery (weeks) 40.6±1.2 39.7±1.1 39.3±1.2 0.079
Percent Body Fat at Study Visit (%)b* 19.4±5.1 19.4±3.4 23.2±3.2†‡ 0.033*
Systolic Blood Pressure (mmHg)* 112.4±11.2 116.3±13.3 117.8±14.6 0.705
Diastolic Blood Pressure (mmHg) 69.1±7.8 70.9±13.0 74.3±8.0 0.564
Parityc n (%) n (%) n (%) 0.201
Primiparous 6 (86%) 7 (50%) 5 (55%)
Multiparous 13 (14%) 7 (50%) 6 (45%)
Ethnicityc n (%) n (%) n (%) 0.515
Caucasian 9 (100%) 13 (93%) 11 (100%)
Hispanic 0 (0%) 1 (7%) 0 (0%)
Educationc n (%) n (%) n (%) 0.147
High School Graduate 2 (29%) 0 (0%) 0 (0%)
Trade School 0 (0%) 0 (0%) 1 (9%)
College Graduate 2 (29%) 6 (43%) 4 (36%)
Post- Graduate Degree 3 (42%) 8 (57%) 6 (55%)
Cholesterol (mg/dL) 290.2±48.7 257.4±40.8 255.6±28.5 0.176
LDL (mg/dL)b 184.2±48.5 145.8±39.2 135.5±35.2 0.064
HDL (mg/dL) 61.1±19.4 76.8±22.2 71.4±23.3 0.365
Triglycerides (mg/dL) 225.2±78.3 173.8±50.7 231.5±85.4 0.107
Free Fatty Acids(meq/L) 0.48±0.12 0.38±0.14 0.42±0.13 0.283
Insulin (uU/mL) 9.5±4.9 9.3±4.6 8.8±3.4 0.943
Glucose (mg/dL) 77.5±7.4 81.7±6.1 80.5±8.3 0.496
HOMA-IR 1.8±1.0 1.9±1.0 1.8±0.8 0.967
a Groups were compared using ANOVA with post-hoc analyses, unless specifically noted
b Groups compared using Kruskal-Wallis tests
cGroups compared using chi-square analysis
*Significant difference between groups (main effect), p<0.05
†Excess GWG group was significantly different from adequate GWG, p<0.05
‡ Excess GWG group was significantly different from inadequate GWG, p<0.05
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relative to kg fat free mass at baseline (R= 0.396, P=
0.027), 2 hours post-meal (R= 0.456, P=0.010), and 4
hours post-meal (R= 0.456, P= 0.010).
The average gestational age for the cohort was 39.7 ±
1.2 weeks, which was not different between maternal
GWG groups (Table 1). The average birthweight for the
cohort was 3400 ± 415 g, ranging from 2670 to 4090 g.
There were no differences in neonatal anthropometric
outcomes (birthweight, measures of adiposity, birth
length, abdominal circumference) when stratified by
Table 2 Maternal metabolic rate and substrate metabolisma
Participants, N = 32 Inadequate (n = 7)
Mean ± SD
Adequate (n = 14)
Mean ± SD




Respiratory Quotient* 0.84 ± 0.07 0.85 ± 0.04 0.78 ± 0.05† 0.006* (0.034–0.491)
Resting Metabolic Rate per Kilogram Fat Free Mass
(kilocalories/day)
27.27 ± 3.20 28.31 ± 4.29 31.97 ± 5.91 0.097 (0.000-0.354)
Lipid Oxidation (grams/minute)* 0.0586 ± 0.0273 0.0569 ± 0.0238 0.1019 ± 0.0416†‡ 0.003* (0.051–0.515)
Lipid Oxidation per Kilogram Fat Free Mass (grams/minute)* 0.0012 ± 0.0006 0.0010 ± 0.0004 0.0017 ± 0.0007† 0.014* (0.012–0.460)
Postprandial (2-hour)
Respiratory Quotient* 0.83 ± 0.07 0.83 ± 0.04 0.77 ± 0.05† 0.015* (0.011–0.448)
Resting Metabolic Rate per Kilogram Fat Free Mass
(kilocalories/day)
34.31 ± 1.93 33.31 ± 4.66 37.38 ± 5.74 0.116 (0.000-0.342)
Lipid Oxidation (grams/minute)* 0.0764 ± 0.0284 0.0782 ± 0.0296 0.1300 ± 0.0490†‡ 0.003* (0.052–0.516)
Lipid Oxidation per Kilogram Fat Free Mass (grams/minute)* 0.0014 ± 0.0007 0.0013 ± 0.0005 0.0021 ± 0.0008† 0.012* (0.015–0.466)
Postprandial (4-hour)
Respiratory Quotient* 0.81 ± 0.06 0.83 ± 0.04 0.73 ± 0.05†‡ < 0.001* (0.160–0.620)
Resting Metabolic Rate per Kilogram Fat Free Mass
(kilocalories/day)
33.47 ± 4.60 32.72 ± 6.51 35.40 ± 4.87 0.501 (0.000-0.212)
Lipid Oxidation (grams/minute)* 0.0863 ± 0.0291 0.0800 ± 0.0259 0.1454 ± 0.0475†‡ < 0.001* (0.0143–0.606)
Lipid Oxidation per Kilogram Fat Free Mass (grams/minute)* 0.0016 ± 0.0007 0.0014 ± 0.0004 0.0024 ± 0.0008† 0.002* (0.076–0.551)
a Groups were compared using ANOVA with post-hoc analyses (because all data were normally distributed)
*Significant difference between groups (main effect), p < 0.05
†Excess GWG group was significantly different from adequate GWG, p < 0.05
‡ Excess GWG group was significantly different from inadequate GWG, p < 0.05
Fig. 1 Maternal Lipid Oxidation
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maternal GWG groups (data not shown). However, ma-
ternal lipid oxidation was positively correlated to infant
birthweight, total skin fold measures, and absolute fat
mass (Fig. 2; Table 3).
Values were similar when controlling for baby’s sex.
Maternal lipid oxidation per kg fat free mass at 4
hours post-meal was positively correlated to birth-
weight (r=0.393, p=0.0326), total skinfolds (r=0.383,
p=0.037) and absolute fat mass (r=0.381, p=0.038)
even after controlling for GWG and pre-pregnancy
BMI. These values were similar when maternal lipid
oxidation was expressed in grams/min.
Discussion
In the present study, we investigated the relationship
between meeting the GWG recommendations and ma-
ternal lipid oxidation among lean women. The main
findings from this study are that lipid oxidation is ele-
vated during late pregnancy among women that were
lean pre-pregnancy and exceed GWG recommendations,
and that maternal lipid oxidation is positively correlated
to baby weight and indicators of baby fat mass, even
after controlling for absolute GWG. The results from
this study indicate that maternal metabolic factors at the
end of pregnancy, specifically lipid oxidation in the
fasted state and in the postprandial state, may play an
important role in GWG and neonatal weight and fat
mass. It is possible that, even among pregnant women
with a lean pre-pregnancy BMI, higher lipid oxidation in
late pregnancy could predispose both mother and neo-
nate to unfavorable metabolic consequences.
We found that lipid oxidation rates, in both the fasting
and postprandial states, were elevated among pregnant
women with a lean pre-pregnancy BMI that went on to
exceed GWG recommendations compared to pregnant
women with a lean pre-pregnancy BMI who met guide-
lines. (Fig. 1). A previous report described an increased
reliance on carbohydrate metabolism during late preg-
nancy among normal weight, metabolically healthy preg-
nant women [26]. However, a recent study by Bugatto
et al. found that pregnant women that are overweight
have an increased reliance on lipid metabolism earlier in
pregnancy and markedly higher lipid metabolism during
late pregnancy compared to their lean counterparts [11].
Their study does not report measures of GWG among
participants. It is possible lipid metabolism among the
women in the current study with excessive GWG experi-
enced a shift in substrate metabolism favoring lipid oxi-
dation earlier in their pregnancy, contributing directly to
the excess accumulation of maternal fat deposition and
GWG.
Previous work among non-pregnant women has
suggested that fat mass gain can result in increasing lipid
oxidation rates, but that other factors beyond fat mass
gain, account for the individual variability in lipid
oxidation observed among women [27]. Given the cross-
sectional design of the study, it is impossible to deter-
mine if the elevated lipid oxidation contributed to the
GWG or rather if the excessive GWG caused the in-
crease in lipid oxidation. Regardless of the order of
events, lean women exceeding the GWG recommenda-
tions in the current study had elevated lipid oxidation in
late pregnancy which is similar to the lipid oxidation
profile among the overweight women in the Bugatto el
al study [11]. To our knowledge, this study is the first
study to provide evidence that elevated lipid oxidation
Fig. 2 Maternal Lipid Oxidation and Infant Fat Mass
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among lean women with excessive GWG could be con-
tributing to an unfavorable metabolic profile similar to
pregnant women with pre-pregnancy overweight/
obesity.
In addition to the implications of unfavorable meta-
bolic adaptations on the mother, the neonates also ap-
pear to be impacted by maternal substrate oxidation as
maternal lipid oxidation was related to infant adiposity
(Fig. 2; Table 3). These findings confirm and elaborate
on the idea that maternal substrate oxidation, beyond
glucose, may play an important role in fetal growth and
development [28–30]. A recent report by Diderholm
et al. suggests lipolysis during late pregnancy is inde-
pendently associated with fetal size [15]. The authors re-
ported that, among pregnant women free of diabetes,
60 % of the variance in fetal weight estimated at 35
weeks gestation could be explained by maternal sub-
strate metabolism. Specifically, they found that maternal
rate of lipolysis was positively associated with fetal
weight and found to be an independent predictor of fetal
weight [15]. Another study by the same group found
that impaired lipolysis in late pregnancy was associated
with intrauterine growth restriction (IUGR) [31]. The
authors suggest that reduced maternal substrate produc-
tion, specifically lipolysis, could decrease the amount of
substrate available for maternal oxidation and thereby
cause a decrease in the amount of glucose available for
the fetus.
Future studies exploring the impact of maternal sub-
strate oxidation on GWG should consider recruiting
women of varying weight statuses. In the current study
we chose to include only women with a lean pre-
pregnancy weight status as maternal overweight/obesity
has been shown to be a risk factor for excessive GWG.
Evidence suggests that lifestyle interventions, such as
diet and exercise, can reduce the risk of excessive GWG
among all pregnant women, including those with obesity
[2]. It is possible that positive impact of lifestyle inter-
ventions on achieving adequate GWG is mediated by
more favorable shifts in maternal substrate utilization.
This study is not without limitations. Objectively
assessed GWG and serial measures of lipid oxidation
and estimates of GWG throughout pregnancy, would
have allowed a more rigorous exploration of the link
between lipid oxidation and GWG. Assessing lipid
oxidation and GWG throughout pregnancy would have
allowed us to determine if women that exceeded the
GWG recommendations had a relatively higher lipid oxi-
dation early in pregnancy, in addition to during late
pregnancy. Future work is needed to determine the clin-
ical utility of assessing maternal substrate metabolism
during pregnancy to predict those at increased risk of
excessive GWG. Another limitation of this study was
that the neonates included did not have extreme devia-
tions from growth that is considered appropriate for
gestational age. Therefore, we cannot determine if the
positive correlation of maternal lipid oxidation to neo-
natal outcomes observed in this study would exist if neo-
nates with more extreme variations in birthweight would
have been included. Future studies should include preg-
nant women with small for gestational age and large for
gestational age suspected fetuses. Also, this study was
conducted among mostly highly educated, non-Hispanic
white women. These findings may not be generalizable
across more diverse populations and future studies
should investigate the impact that maternal lipid oxida-
tion has on gestational weight gain and neonatal out-
comes among women from diverse racial and ethnic
backgrounds.
Conclusions
This study investigated the relationship between meeting
the GWG recommendations and maternal lipid oxida-
tion among lean women. Lipid oxidation is elevated
during late pregnancy among women that were lean pre-
pregnancy and exceed GWG recommendations.
Additionally, maternal lipid oxidation was positively cor-
related to baby weight and indicators of baby fat mass,
even after controlling for absolute GWG. Maternal
metabolic factors at the end of pregnancy, specifically
lipid oxidation in the fasted state and in the postprandial
state, may play an important role in GWG and neonatal
weight and fat mass. Higher lipid oxidation in late preg-
nancy could predispose both mother and neonate to
Table 3 Relationship between maternal lipid oxidation and infant anthropometrics (N=32)
Lipid Oxidation (grams/minute) Baseline 2-Hour 4-Hour
Birthweight (grams) R= 0.426 P= 0.015* R= 0.393 P= 0.026* R= 0.540 P= 0.001*
Total Skin Folds (millimeters) R= 0.380 P= 0.032* R= 0.243 P= 0.181 R= 0.362 P= 0.042*
Absolute Fat Mass (kilograms) [25] R= 0.493 P= 0.004* R= 0.450 P= 0.010* R= 0.552 P= 0.001*
Lipid Oxidation per Kilogram Fat Free Mass (grams/minute) Baseline 2-Hour 4-Hour
Birthweight (grams) R= 0.388 P= 0.031* R= 0.365 P= 0.044* R= 0.502 P= 0.004*
Total Skin Folds (millimeters) R= 0.428 P= 0.016* R= 0.295 P= 0.107 R= 0.413 P= 0.021*
Absolute Fat Mass (kilograms) [25] R= 0.450 P= 0.011* R= 0.418 P= 0.019* R= 0.510 P= 0.003*
*Significant correlation p<0.05
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unfavorable metabolic consequences, even among preg-
nant women with a lean pre-pregnancy weight status. A
better understanding of the metabolic profile of women
during pregnancy, including maternal lipid metabolism,
could prove useful in terms of identifying women at
risk for adverse pregnancy outcomes such as excessive
GWG.
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